Artwork

内容由Genetic Engineering and Society Center, NC State, Genetic Engineering, Society Center, and NC State提供。所有播客内容(包括剧集、图形和播客描述)均由 Genetic Engineering and Society Center, NC State, Genetic Engineering, Society Center, and NC State 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

S11E1 - Moussa Savadogo - Regulating genetic-based vector control towards malaria elimination in Africa

58:25
 
分享
 

Manage episode 462366595 series 2982476
内容由Genetic Engineering and Society Center, NC State, Genetic Engineering, Society Center, and NC State提供。所有播客内容(包括剧集、图形和播客描述)均由 Genetic Engineering and Society Center, NC State, Genetic Engineering, Society Center, and NC State 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Regulating genetic-based vector control towards malaria elimination in Africa: Key considerations, challenges and opportunities

Zoom | Genetic-based approaches offer promising solutions for malaria in sub-Saharan Africa. Clear regulations and public acceptance are essential for their success.

Moussa Savadogo, PhD

Senior Research Fellow at the African Institute for Development Policy (AFIDEP) | Profile Dr. Moussa Savadogo is an environmental biosafety expert from Burkina Faso with extensive experience in regulatory capacity building and stakeholder engagement. He served for 15 years as a Principal Programme Officer at the African Union Development Agency – New Partnership for Africa’s Development (AUDA-NEPAD), where he led the environmental component of regulatory capacity building in Agricultural Biotechnology (ABNE) and Integrated Vector Management (IVM). After retiring from AUDA-NEPAD, Dr. Savadogo continued to support the organization as a Technical Consultant with WITS Health Consortium (Pty) Ltd in Johannesburg. In this role, he contributed to building regulatory capacity and engaging high-level stakeholders on genetically based vector control strategies aimed at eliminating malaria and other vector-borne diseases. Dr. Savadogo recently joined the African Institute for Development Policy (AFIDEP) as a Senior Research Fellow. In this capacity, he provides policy advisory services to African Union Member States on innovative vector control strategies, including gene drives for malaria elimination and Wolbachia endosymbiont mosquitoes for dengue control. Earlier in his career, Dr. Savadogo worked as a scientist at Burkina Faso’s National Centre of Research and Technology (CNRST) and as a regulator at the National Biosafety Agency (ANB). His career reflects a commitment to advancing biosafety and sustainable solutions for pressing public health challenges in Africa.

Abstract

Malaria continues to be the most devastating disease in sub-Saharan Africa, where a child dies from the infection every one to two minutes. According to the World Health Organization’s (WHO) World Malaria Report, progress has alarmingly stalled in the WHO African Region, which accounts for approximately 95% of global malaria morbidity and mortality. It is increasingly evident that no single strategy will suffice to eliminate malaria by 2030, as outlined in the Global Technical Strategy for Malaria 2016–2030 (GTS). Contributing factors—such as mosquito resistance to insecticides, parasite resistance to antimalarial drugs, shifting mosquito behaviors, global warming, armed conflicts, and inadequate funding—compound the challenge. Additionally, dengue cases continue to rise. In response, there is an urgent need to explore innovative tools, including genetically modified mosquitoes equipped with engineered gene drives, as recommended by the African Union High-Level Panel on Emerging Technologies (APET). Though progress is underway in several African countries, significant ethical and environmental concerns persist. A favorable regulatory environment is therefore critical to enable responsible research and development of these tools. Key enabling factors include (i) strong political commitment at national and regional levels, (ii) functional regulatory systems, (iii) strengthened health research capacities, (iv) public acceptance of genetic-based technologies, and (v) enhanced regional and multilateral collaboration.


The Genetic Engineering and Society (GES) Colloquium is a seminar series that brings in speakers to present and stimulate discussion on a variety of topics related to existing and proposed biotechnologies and their place within broader societal changes.

GES Colloquium is jointly taught by Drs. Katie Barnhill and Nourou Barry, who you may contact with any class-specific questions. Colloquium meets weekly on Tuesdays from 12-1 pm via Zoom, with national/international guests joining us remotely, and local in-person guests every other week in Withers 331.

Please subscribe to the GES newsletter and LinkedIn for updates.

Genetic Engineering and Society Center

Colloquium Home | Zoom Registration | Watch Colloquium Videos | LinkedIn | Newsletter

GES Center at NC State University—Integrating scientific knowledge & diverse public values in shaping the futures of biotechnology.

Find out more at https://ges-center-lectures-ncsu.pinecast.co

  continue reading

120集单集

Artwork
icon分享
 
Manage episode 462366595 series 2982476
内容由Genetic Engineering and Society Center, NC State, Genetic Engineering, Society Center, and NC State提供。所有播客内容(包括剧集、图形和播客描述)均由 Genetic Engineering and Society Center, NC State, Genetic Engineering, Society Center, and NC State 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Regulating genetic-based vector control towards malaria elimination in Africa: Key considerations, challenges and opportunities

Zoom | Genetic-based approaches offer promising solutions for malaria in sub-Saharan Africa. Clear regulations and public acceptance are essential for their success.

Moussa Savadogo, PhD

Senior Research Fellow at the African Institute for Development Policy (AFIDEP) | Profile Dr. Moussa Savadogo is an environmental biosafety expert from Burkina Faso with extensive experience in regulatory capacity building and stakeholder engagement. He served for 15 years as a Principal Programme Officer at the African Union Development Agency – New Partnership for Africa’s Development (AUDA-NEPAD), where he led the environmental component of regulatory capacity building in Agricultural Biotechnology (ABNE) and Integrated Vector Management (IVM). After retiring from AUDA-NEPAD, Dr. Savadogo continued to support the organization as a Technical Consultant with WITS Health Consortium (Pty) Ltd in Johannesburg. In this role, he contributed to building regulatory capacity and engaging high-level stakeholders on genetically based vector control strategies aimed at eliminating malaria and other vector-borne diseases. Dr. Savadogo recently joined the African Institute for Development Policy (AFIDEP) as a Senior Research Fellow. In this capacity, he provides policy advisory services to African Union Member States on innovative vector control strategies, including gene drives for malaria elimination and Wolbachia endosymbiont mosquitoes for dengue control. Earlier in his career, Dr. Savadogo worked as a scientist at Burkina Faso’s National Centre of Research and Technology (CNRST) and as a regulator at the National Biosafety Agency (ANB). His career reflects a commitment to advancing biosafety and sustainable solutions for pressing public health challenges in Africa.

Abstract

Malaria continues to be the most devastating disease in sub-Saharan Africa, where a child dies from the infection every one to two minutes. According to the World Health Organization’s (WHO) World Malaria Report, progress has alarmingly stalled in the WHO African Region, which accounts for approximately 95% of global malaria morbidity and mortality. It is increasingly evident that no single strategy will suffice to eliminate malaria by 2030, as outlined in the Global Technical Strategy for Malaria 2016–2030 (GTS). Contributing factors—such as mosquito resistance to insecticides, parasite resistance to antimalarial drugs, shifting mosquito behaviors, global warming, armed conflicts, and inadequate funding—compound the challenge. Additionally, dengue cases continue to rise. In response, there is an urgent need to explore innovative tools, including genetically modified mosquitoes equipped with engineered gene drives, as recommended by the African Union High-Level Panel on Emerging Technologies (APET). Though progress is underway in several African countries, significant ethical and environmental concerns persist. A favorable regulatory environment is therefore critical to enable responsible research and development of these tools. Key enabling factors include (i) strong political commitment at national and regional levels, (ii) functional regulatory systems, (iii) strengthened health research capacities, (iv) public acceptance of genetic-based technologies, and (v) enhanced regional and multilateral collaboration.


The Genetic Engineering and Society (GES) Colloquium is a seminar series that brings in speakers to present and stimulate discussion on a variety of topics related to existing and proposed biotechnologies and their place within broader societal changes.

GES Colloquium is jointly taught by Drs. Katie Barnhill and Nourou Barry, who you may contact with any class-specific questions. Colloquium meets weekly on Tuesdays from 12-1 pm via Zoom, with national/international guests joining us remotely, and local in-person guests every other week in Withers 331.

Please subscribe to the GES newsletter and LinkedIn for updates.

Genetic Engineering and Society Center

Colloquium Home | Zoom Registration | Watch Colloquium Videos | LinkedIn | Newsletter

GES Center at NC State University—Integrating scientific knowledge & diverse public values in shaping the futures of biotechnology.

Find out more at https://ges-center-lectures-ncsu.pinecast.co

  continue reading

120集单集

כל הפרקים

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南

边探索边听这个节目
播放